Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
M611752-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,300.90 | |
M611752-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,000.90 |
Synonyms | α-methylene-γ-butyrolactone 3 |
---|---|
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of lysine acetyltransferase 2B |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | (2S,3S)-4,5-dioxo-2-propyloxolane-3-carboxylic acid |
---|---|
INCHI | InChI=1S/C8H10O5/c1-2-3-4-5(7(10)11)6(9)8(12)13-4/h4-5H,2-3H2,1H3,(H,10,11)/t4-,5-/m0/s1 |
InChi Key | AKWJFOMNTDKSRR-WHFBIAKZSA-N |
Canonical SMILES | CCC[C@@H]1OC(=O)C(=O)[C@H]1C(=O)O |
Isomeric SMILES | CCC[C@H]1[C@@H](C(=O)C(=O)O1)C(=O)O |
PubChem CID | 91827357 |
PubChem CID | 91827357 |
---|
Enter Lot Number to search for COA:
1. Lee KK, Workman JL. (2007) Histone acetyltransferase complexes: one size doesn't fit all.. Nat Rev Mol Cell Biol, 8 (4): (284-95). [PMID:17380162] |
2. Biel M, Kretsovali A, Karatzali E, Papamatheakis J, Giannis A. (2004) Design, synthesis, and biological evaluation of a small-molecule inhibitor of the histone acetyltransferase Gcn5.. Angew Chem Int Ed Engl, 43 (30): (3974-6). [PMID:15274229] |
3. Holmlund T, Lindberg MJ, Grander D, Wallberg AE. (2013) GCN5 acetylates and regulates the stability of the oncoprotein E2A-PBX1 in acute lymphoblastic leukemia.. Leukemia, 27 (3): (578-85). [PMID:23044487] |
4. Carroll AJ, Crist WM, Parmley RT, Roper M, Cooper MD, Finley WH. (1984) Pre-B cell leukemia associated with chromosome translocation 1;19.. Blood, 63 (3): (721-4). [PMID:6607758] |
5. Dahlin JL, Nelson KM, Strasser JM, Barsyte-Lovejoy D, Szewczyk MM, Organ S, Cuellar M, Singh G, Shrimp JH, Nguyen N et al.. (2017) Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors.. Nat Commun, 8 (1): (1527). [PMID:29142305] |